Lanean...
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
Targeted T cells are emerging as effective non-toxic therapies for cancer. Multiple elements, however, contribute to the overall pathogenesis of cancer through both distinct and redundant mechanisms. Hence, targeting multiple cancer-specific markers simultaneously could result in better therapeutic...
Gorde:
Egile Nagusiak: | , , , , , , , , , , , , , , |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
Nature Publishing Group
2013
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3731887/ https://ncbi.nlm.nih.gov/pubmed/23839099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2013.32 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|